Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Povidone-iodine + isopropyl alcohol + lidocaine hydrochloride + bupivacaine** describes a multi-component procedural anesthesia and skin-preparation combination rather than a uniquely identified branded drug product. Povidone-iodine and isopropyl alcohol provide topical antisepsis before an invasive procedure. Lidocaine hydrochloride and bupivacaine are amide local anesthetics that reversibly inhibit voltage-gated sodium channels in peripheral nerves, producing rapid-onset and longer-duration local or regional anesthesia, respectively. The combination is consistent with a procedural kit or co-packaged supply used for infiltration anesthesia, regional nerve block, or epidural procedures, but no specific product with exactly these four listed active ingredients was identified.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on povidone-iodine + isopropyl alcohol + lidocaine hydrochloride + bupivacaine.